English 
Deutsch
Polski
OATin Technology®, developed by the Phoenix 2050 Group, is an advanced oat biorefining technology that enables the isolation of various oat components in their most valuable form. This innovative method, developed in the last 12 years by experts, enthusiasts and investors of the Phoenix 2050 Group, makes it possible to precisely control the production process, to offer products with different characteristics, consistent with market expectations and consumer needs.
Owing to OATin Technology®, we are able to obtain the key ingredient in QUUS – beta glucan isolate from oats, whose effectiveness in supporting EGUS treatment has been confirmed in clinical trials. This innovative ingredient, obtained by virtue of our technology, is an important contribution to the development of modern animal therapies.
WE DRAW INSPIRATION FROM NATURE
The success of the efficacy of our beta glucan
1-3 , 1-4 β-D-glucan, a non-cellulosic polysaccharide, is extracted from the kernel of the oat seed Avena sativa L. or parts thereof (bran, oat fiber) according to a patented method. The highly purified product can contain up to 95% beta-glucan in its composition. The remainder (5-20%) is made up of starch, protein, insoluble fiber and water in particular. The characteristics resulting from its purity are its total solubility, odorlessness, colorlessness and tastelessness. When combined with water even at very low concentrations, it forms stable gelatine that protects the walls of the digestive system from chemical and physical agents. Beta glucan also promotes the formation of normal bacterial flora in the digestive system.
How do we obtain it?
To fractionate oats into isolated components, we use the capabilities of OATin TECHNOLOGY. With this proprietary method, we can obtain each isolated ingredient in its most valuable form. The products we obtain through this process are oat oil, insoluble fiber, oat protein, starch and the key ingredient oat beta glucan isolate, the effectiveness of which has been proven in clinical trials.
OUR CONTRIBUTIONS ARE ACKNOWLEDGED IN POLAND AND AROUND THE WORLD
Our work on beta glucan isolate from oats has been recognized by the Polish Product of the Future competition, as well as the EIT Food program. In addition, we had the honor of participating in the prestigious MASSCHALLENGE US RAISING STARTUP program.
